MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6402-447-455$20.00
Mol Pharmacol 64:447-455, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, M.
Right arrow Articles by Ye, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, M.
Right arrow Articles by Ye, R. D.

Requirement of G{beta}{gamma} and c-Src in D2 Dopamine Receptor-Mediated Nuclear Factor-{kappa}B Activation

Ming Yang1, Hongmei Zhang1, Tatyana Voyno-Yasenetskaya, and Richard D. Ye

Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois

The D2 dopamine receptor (D2R) was examined for its ability to mediate nuclear factor-{kappa}B (NF-{kappa}B) activation through G proteins. Stimulation of D2R-transfected HeLa cells with its agonist quinpirole induced the expression of a NF-{kappa}B luciferase reporter and formation of NF-{kappa}B-DNA complex. This response was blocked by pertussis toxin, and by the G{beta}{gamma} scavengers transducin and {beta}-adrenergic receptor kinase 1 carboxyl-terminal fragment. Unlike Gi-coupled chemoattractant receptors, D2R activated NF-{kappa}B without an increase in phospholipase C-{beta} activity, and the response was only slightly affected by the phosphoinositide 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). In contrast, treatment with genistein and 4-amino-1-tert-butyl-3-(p-methylphenyl)pyrazolo[3,4-d] pyrimidine abolished the induced NF-{kappa}B activation, suggesting involvement of protein tyrosine kinases. Activation of D2R led to phosphorylation of c-Src at Tyr-418, and expression of a kinase-deficient c-Src inhibited D2R-mediated NF-{kappa}B activation. The D2R-mediated NF-{kappa}B activation was not dependent on epidermal growth factor (EGF) receptor transactivation since 4-(3'-chloroanilino)-6,7-dimethoxyquinazoline (AG1478), an EGF receptor-selective tyrphostin used at 1 µM, blocked EGF-induced NF-{kappa}B activation but not the quinpirole-induced response. In addition, the D2R-mediated NF-{kappa}B activation was enhanced by over-expression of {beta}-arrestin 1. These results suggest that D2R-mediated NF-{kappa}B activation requires G{beta}{gamma} and c-Src, and possibly involves {beta}-arrestin 1.


Received April 10, 2003; accepted May 9, 2003

Address correspondence to: Richard D. Ye, Department of Pharmacology, M/C 868, University of Illinois at Chicago, 835 S. Wolcott Avenue, Chicago, IL 60612. E-mail: yer{at}uic.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
W. Zhang, J.-M. Navenot, N. M. Frilot, N. Fujii, and S. C. Peiper
Association of Nucleophosmin Negatively Regulates CXCR4-Mediated G Protein Activation and Chemotaxis
Mol. Pharmacol., November 1, 2007; 72(5): 1310 - 1321.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Bontempi, C. Fiorentini, C. Busi, N. Guerra, P. Spano, and C. Missale
Identification and Characterization of Two Nuclear Factor-{kappa}B Sites in the Regulatory Region of the Dopamine D2 Receptor
Endocrinology, May 1, 2007; 148(5): 2563 - 2570.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-H. Lin, H.-W. Cheng, M.-J. Hsu, M.-C. Chen, C.-C. Lin, and B.-C. Chen
c-Src Mediates Thrombin-Induced NF-{kappa}B Activation and IL-8/CXCL8 Expression in Lung Epithelial Cells.
J. Immunol., September 1, 2006; 177(5): 3427 - 3438.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. F. Liu and Y. H. Wong
Activation of Nuclear Factor {kappa}B by Somatostatin Type 2 Receptor in Pancreatic Acinar AR42J Cells Involves G{alpha}14 and Multiple Signaling Components: A MECHANISM REQUIRING PROTEIN KINASE C, CALMODULIN-DEPENDENT KINASE II, ERK, AND c-Src
J. Biol. Chem., October 14, 2005; 280(41): 34617 - 34625.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. F. Liu and Y. H. Wong
G16-mediated Activation of Nuclear Factor {kappa}B by the Adenosine A1 Receptor Involves c-Src, Protein Kinase C, and ERK Signaling
J. Biol. Chem., December 17, 2004; 279(51): 53196 - 53204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Bakker, P. Casarosa, H. Timmerman, M. J. Smit, and R. Leurs
Constitutively active Gq/11-coupled Receptors Enable Signaling by Co-expressed Gi/o-coupled Receptors
J. Biol. Chem., February 13, 2004; 279(7): 5152 - 5161.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics